Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a New Sequencing Strategy in Autoinflammatory Diseases Diagnostic Value and Therapeutic Orientation

NCT02976948 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT02976948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02976948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a New Sequencing Strategy in Autoinflammatory Diseases Diagnostic Value and Therapeutic Orientation
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Terminated
Start date
July 31, 2015
Completion date
March 31, 2020
Enrollment
299 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic autoinflammatory diseases (said)